Stock Fundamentals

Company Information

Company Name
GRAIL, LLC
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
ISIN: US3847471014
CIK: 0001699031
CUSIP: 384747101
Currency: USD
Full Time Employees: 910
Phone: 833 694 2553
Fiscal Year End: December
IPO Date: Jun 25, 2024
Description:

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Address:

1525 O?Brien Drive, Menlo Park, CA, United States, 94025

Directors & Officers

Name Title Year Born
Dr. Joshua J. Ofman M.D., M.S.H.S CEO & Director 1965
Mr. Aaron Freidin CFO & Head of Corporate Development 1979
Mr. Robert P. Ragusa Advisor 1960
Mr. Paul Ciccolella Senior Vice President of Global Development & Operations NA
Sir Harpal S. Kumar M.A., M.B.A., MEng Chief Scientific Officer and President of Global Clinical & Medical Affairs NA
Mr. Abram Barth J.D., M.P.H. Chief Legal Officer & Corporate Secretary NA
Ms. Trish Rowland Senior Vice President of Corporate Communications NA
Ms. Alison Highlander Senior VP of Human Resources & Head of People Team NA
Dr. Satnam Alag Ph.D. Senior VP of Software Engineering & Chief Security Officer NA
Mr. Andrew John Partridge Chief Growth Officer 1969

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 08, 2026 Joshua J Ofman N/A Sale 61.67K $49.92 $3.08M
Apr 08, 2026 Robert P Ragusa N/A Sale 123.50K $49.92 $6.17M
Apr 08, 2026 Aaron Freidin N/A Sale 45.81K $49.92 $2.29M
Mar 09, 2026 Aaron Freidin N/A Sale 2.49K $47.89 $119.34K
Mar 09, 2026 Joshua J Ofman N/A Sale 2.94K $47.89 $140.65K
Mar 09, 2026 Robert P Ragusa N/A Sale 7.46K $47.89 $357.31K
Mar 05, 2026 Aaron Freidin N/A Sale 655.00 $53.01 $34.72K
Mar 05, 2026 Joshua J Ofman N/A Sale 690.00 $53.01 $36.58K
Mar 05, 2026 Robert P Ragusa N/A Sale 980.00 $53.01 $51.95K
Mar 02, 2026 Aaron Freidin N/A Sale 9.57K $50.17 $480.28K
Mar 02, 2026 Joshua J Ofman N/A Sale 17.00K $50.16 $852.82K
Mar 02, 2026 Robert P Ragusa N/A Sale 37.50K $50.17 $1.88M
Oct 16, 2025 Joshua J Ofman N/A Sale 6.11K $82.01 $501.41K
Oct 15, 2025 Joshua J Ofman N/A Sale 8.87K $76.03 $674.01K
Oct 15, 2025 Robert P Ragusa N/A Sale 7.24K $68.88 $498.62K
Oct 06, 2025 Joshua J Ofman N/A Sale 81.39K $62.50 $5.09M
Oct 02, 2025 Joshua J Ofman N/A Sale 9.69K $64.00 $620.29K
Aug 19, 2025 Joshua J Ofman N/A Sale 4.20K $32.02 $134.55K
Jul 15, 2025 Aaron Freidin N/A Sale 8.00K $38.93 $311.44K
Jul 01, 2025 Chun R Ding N/A Sale 339.80K $49.53 $16.83M

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Baker Bros Advisors LP 4.03M Mar 31, 2026 9.39% $1.20 93.19%
Farallon Capital Management, L.L.C. 3.25M Mar 31, 2026 7.58% $0.96 38.89%
BlackRock Inc 2.97M Mar 31, 2026 6.92% $0.00 0.35%
Vanguard Group Inc 1.98M Dec 31, 2025 4.62% $0.00 9.01%
State Street Corp 1.89M Mar 31, 2026 4.41% $0.00 3.52%
PRIMECAP Management Company 1.84M Mar 31, 2026 4.30% $0.08 0.28%
Deep Track Capital, LP 1.72M Mar 31, 2026 4.01% $1.45 68.44%
Sessa Capital, L.P 1.72M Mar 31, 2026 4.01% $1.61 371.41%
Morgan Stanley - Brokerage Accounts 1.63M Mar 31, 2026 3.80% $0.01 7.97%
Vanguard Capital Management, LLC 1.53M Mar 31, 2026 3.56% $0.00 0.00%
Fort Hoosac Management, LLC 1.03M Mar 31, 2026 2.41% $30.64 -0.10%
Bank of America Corp 914.11K Mar 31, 2026 2.13% $0.00 29.02%
Geode Capital Management, LLC 827.94K Mar 31, 2026 1.93% $0.00 3.30%
Jefferies Financial Group Inc 657.50K Mar 31, 2026 1.53% $0.23 0.00%
Alyeska Investment Group, L.P. 645.46K Mar 31, 2026 1.50% $0.09 45.87%
The Goldman Sachs Group Inc 581.92K Mar 31, 2026 1.36% $0.00 8.37%
RA Capital Management, LLC 428.27K Mar 31, 2026 1.00% $0.23 0.00%
Dimensional Fund Advisors, Inc. 408.65K Mar 31, 2026 0.95% $0.00 88.50%
Northern Trust Corp 349.14K Mar 31, 2026 0.81% $0.00 2.26%
Vanguard Portfolio Management, LLC 334.91K Mar 31, 2026 0.78% $0.00 0.00%

Shares Statistics

Shares Outstanding: 42.92M
Shares Float: 33.47M
% Insiders: 522.70%
% Institutions: 8,352.80%
Short % Float: 16.83%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 PRIMECAP Odyssey Aggressive Growth 1.31M 3.05% ▲ 0.10% Mar 31, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.16M 2.71% ▲ 0.31% Apr 30, 2026
3 State Street® SPDR® S&P® Biotech ETF 1.15M 2.69% ▼ 0.61% May 31, 2026
4 iShares Russell 2000 ETF 838.69K 1.95% ▲ 0.93% May 29, 2026
5 Fidelity Small Cap Index 344.87K 0.80% ▲ 0.19% Mar 31, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 334.04K 0.78% ▲ 0.97% Apr 30, 2026
7 iShares Russell 2000 Value ETF 305.27K 0.71% ▲ 0.73% May 29, 2026
8 iShares Biotechnology ETF 286.53K 0.67% ▲ 12.40% May 29, 2026
9 Vanguard US Opportunities Ins USD Acc 257.72K 0.60% ▲ 1.58% Mar 31, 2026
10 Russell 2000 Equity Index Fund B 217.37K 0.51% ▲ 9.36% Dec 31, 2025

Valuation Metrics

Enterprise Value: $2.48B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $3.09B
EBITDA: $-360.50M
Book Value: $60.79
Earnings/Share: $-9.78
Profit Margin: -253.22%
Operating Margin: -332.88%
ROA (TTM): -11.42%
ROE (TTM): -16.09%
Revenue (TTM): $156.12M
Revenue/Share (TTM): $4.07
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 28.10%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 11.97x 0.00x 0.12x N/A -0.03x
2024-12-31 10.66x 0.01x 0.16x N/A -0.02x
2023-12-31 0.95x 0.00x 0.20x N/A -0.02x
2022-12-31 2.19x 0.00x 0.17x N/A -0.02x
2021-12-31 2.48x 0.00x 0.03x N/A -0.01x
2020-12-31 7.10x 0.01x 0.20x N/A -0.02x
2019-12-31 12.41x 0.01x 0.13x N/A -0.02x
2018-12-31 8.75x 0.00x 0.13x N/A -0.01x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about GRAL.US!